These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11148549)

  • 1. Alternative pathway therapy for urea cycle disorders: twenty years later.
    Batshaw ML; MacArthur RB; Tuchman M
    J Pediatr; 2001 Jan; 138(1 Suppl):S46-54; discussion S54-5. PubMed ID: 11148549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative-pathway therapy for hyperammonemia.
    Shih VE
    N Engl J Med; 2007 May; 356(22):2321-2. PubMed ID: 17538092
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy.
    Atiq M; Holt AF; Safdar K; Weber F; Ravinuthala R; Jonas ME; Neff GW
    J Clin Gastroenterol; 2008 Feb; 42(2):213-4. PubMed ID: 18209596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term management of patients with urea cycle disorders.
    Berry GT; Steiner RD
    J Pediatr; 2001 Jan; 138(1 Suppl):S56-60; discussion S60-1. PubMed ID: 11148550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current strategies for the management of neonatal urea cycle disorders.
    Summar M
    J Pediatr; 2001 Jan; 138(1 Suppl):S30-9. PubMed ID: 11148547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argininosuccinate lyase deficiency.
    Nagamani SC; Erez A; Lee B
    Genet Med; 2012 May; 14(5):501-7. PubMed ID: 22241104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of urea cycle disorders.
    Batshaw ML; Monahan PS
    Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative pathway therapy for urea cycle disorders.
    Feillet F; Leonard JV
    J Inherit Metab Dis; 1998; 21 Suppl 1():101-11. PubMed ID: 9686348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of girls with ornithine transcarbamylase deficiency.
    Maestri NE; Brusilow SW; Clissold DB; Bassett SS
    N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia toxicity and its prevention in inherited defects of the urea cycle.
    Walker V
    Diabetes Obes Metab; 2009 Sep; 11(9):823-35. PubMed ID: 19531057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of urea cycle disorders.
    Thoene JG
    J Pediatr; 1999 Mar; 134(3):255-6. PubMed ID: 10064655
    [No Abstract]   [Full Text] [Related]  

  • 17. Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.
    Praphanphoj V; Boyadjiev SA; Waber LJ; Brusilow SW; Geraghty MT
    J Inherit Metab Dis; 2000 Mar; 23(2):129-36. PubMed ID: 10801054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency.
    Imataka G; Ishii J; Ando Y; Yoshihara S; Takagi Y; Nitta A; Arisaka O; Yoshihara S
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10051-10053. PubMed ID: 33090410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperammonemia type II as an example of urea cycle disorder].
    Hawrot-Kawecka AM; Kawecki GP; Duława J
    Wiad Lek; 2006; 59(7-8):512-5. PubMed ID: 17209350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.
    Bunchman TE; Barletta GM; Winters JW; Gardner JJ; Crumb TL; McBryde KD
    Pediatr Nephrol; 2007 Jul; 22(7):1062-5. PubMed ID: 17277951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.